SCHEMBL6174046

SCHEMBL6174046

COc1ccncc1CN1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TSHR P16473 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.50
CACNA1B Q00975 1/20 0.49
HTT P42858 1/20 0.47
GAA P10253 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNA4 P43681 1/20 0.45
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL5790927 0.86 MEN1 (0.60) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL17828166 0.84 ACHE (0.47) KDM4EKMT2AALDH1A1HTTGAA
SCHEMBL2495479 0.81 KMT2A (0.44) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL17828051 0.79 CHRNB4 (0.41) KDM4EKMT2AALDH1A1HTTGAA
SCHEMBL3161038 0.77 MEN1 (0.82) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL27644587 0.76 GAA (0.54) KDM4EKMT2AALDH1A1GAAHRH3
SCHEMBL27643123 0.76 GNAI3 (0.39) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL13284339 0.75 MEN1 (0.79) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL24582721 0.73 CACNA1B (0.50) KDM4ETDP1ALDH1A1L3MBTL1CACNA1B
SCHEMBL20476270 0.73 CHRNB2 (0.50) KDM4EMEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1875017-A Naphthalene-1, 5-disulfonic acid salts of substituted 4-amino-1- (pyridylmethyl) piperidine compounds THERAVANCE INC (US) 2006-12-06 CN claimed
EP-1556372-A2 SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2005-07-27 EP claimed
WO-2004041806-A2 SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2004-05-21 WO claimed
CN-100364990-C Substituted 4-amino-1- (pyridylmethyl) piperidines and related compounds THERAVANCE INC (US) 2008-01-30 CN disclosed
CN-1875017-A Naphthalene-1, 5-disulfonic acid salts of substituted 4-amino-1- (pyridylmethyl) piperidine compounds THERAVANCE INC (US) 2006-12-06 CN disclosed
CN-1708494-A Substituted 4-amino-1- (pyridylmethyl) piperidines and related compounds THERAVANCE INC (US) 2005-12-14 CN disclosed
EP-1556372-A2 SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2005-07-27 EP disclosed
WO-2004041806-A2 SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2004-05-21 WO disclosed